tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

TSE:CYBN Stock Latest News

Cybin Advances Phase 3 Program Amid Positive Regulatory Signals
Company AnnouncementsCybin Advances Phase 3 Program Amid Positive Regulatory Signals
3d ago
CYBN
Psychedelic: Clearmind engages government, political affairs consulting firm
PremiumThe Fly
Psychedelic: Clearmind engages government, political affairs consulting firm
4d ago
ATAI
CMND
Cybin CEO to Present at Neuro Perspectives Conference
PremiumCompany Announcements
Cybin CEO to Present at Neuro Perspectives Conference
4d ago
CYBN
Cybin CEO to Speak at Psychedelic Science 2025 Conference
PremiumCompany Announcements
Cybin CEO to Speak at Psychedelic Science 2025 Conference
5d ago
CYBN
Cybin initiated with a Buy at Lucid Capital
PremiumThe Fly
Cybin initiated with a Buy at Lucid Capital
10d ago
CYBN
Psychedelic: atai, Beckly Psytech to combine in all-share transaction
PremiumThe FlyPsychedelic: atai, Beckly Psytech to combine in all-share transaction
11d ago
ATAI
CMND
Cybin Secures U.S. Patent for CYB004 Program in Anxiety Disorder Treatment
Premium
Company Announcements
Cybin Secures U.S. Patent for CYB004 Program in Anxiety Disorder Treatment
13d ago
CYBN
Cybin announces additional U.S. patent supporting CYB004
Premium
The Fly
Cybin announces additional U.S. patent supporting CYB004
13d ago
CYBN
Cybin CEO to Discuss Strategic Advances at Upcoming Fireside Chat
PremiumCompany Announcements
Cybin CEO to Discuss Strategic Advances at Upcoming Fireside Chat
25d ago
CYBN
Cybin Supports FDA’s Push for Psychedelic Research
PremiumCompany Announcements
Cybin Supports FDA’s Push for Psychedelic Research
27d ago
CYBN
VA secretary wants to find answers on psychedelics therapies, Politico says
PremiumThe Fly
VA secretary wants to find answers on psychedelics therapies, Politico says
1M ago
ATAI
CYBN
Psychedelic: Atai, Enveric, Incannex and Relmada report quarterly results
PremiumThe Fly
Psychedelic: Atai, Enveric, Incannex and Relmada report quarterly results
1M ago
TMO
ATAI
Cybin Partners with Thermo Fisher for U.S. Manufacturing of CYB003
PremiumCompany AnnouncementsCybin Partners with Thermo Fisher for U.S. Manufacturing of CYB003
1M ago
CYBN
Cybin engages Thermo Fisher to support CYB003 supply, manufacturing
Premium
The Fly
Cybin engages Thermo Fisher to support CYB003 supply, manufacturing
1M ago
TMO
CYBN
Cybin CEO to Speak at Healthcare Showcase, Highlighting Innovations in Mental Health Treatment
Premium
Company Announcements
Cybin CEO to Speak at Healthcare Showcase, Highlighting Innovations in Mental Health Treatment
1M ago
CYBN
Psychedelic: Compass, GH Research, MindMed report quarterly earnings
PremiumThe Fly
Psychedelic: Compass, GH Research, MindMed report quarterly earnings
1M ago
CMPS
CYBN
Cybin announces USPTO patent in support of CYB003 program
PremiumThe Fly
Cybin announces USPTO patent in support of CYB003 program
1M ago
CYBN
Cybin Secures New U.S. Patent for CYB003 Program in Major Depressive Disorder
PremiumCompany Announcements
Cybin Secures New U.S. Patent for CYB003 Program in Major Depressive Disorder
1M ago
CYBN
Cybin CEO to Speak at Milken Institute Global Conference on Medical Breakthroughs
PremiumCompany Announcements
Cybin CEO to Speak at Milken Institute Global Conference on Medical Breakthroughs
2M ago
CYBN
Psychedelic: Clearmind completes clinical site initiations for AUD trial
PremiumThe FlyPsychedelic: Clearmind completes clinical site initiations for AUD trial
2M ago
CMND
CMPS
Cybin Expands Strategic Partnerships for Phase 3 MDD Treatment Trials
Premium
Company Announcements
Cybin Expands Strategic Partnerships for Phase 3 MDD Treatment Trials
2M ago
CYBN
Cybin announces additional CYB003 strategic partnership agreements
Premium
The Fly
Cybin announces additional CYB003 strategic partnership agreements
2M ago
CYBN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >